HIGH SENSITIVITY C-REACTIVE PROTEIN AND PLASMA LIPIDS IN TYPE 2DIABETIC PATIENTS IN ENUGU, NIGERIA.

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2017, Vol 4, Issue 11

Abstract

Background: Type II Diabetes is a worldwide health problem. It exerts a heavy economic burden on the society and is associated with microvascular and macrovascular complications. Objective: This study on high sensitivity C-reactive protein (hs-CRP) and plasma lipids in type II diabetic patients was carried out to have a baseline data of hs-CRP and plasma lipids in type II diabetics and its relation to glycaemic control. Methods: In this cross-sectional study 150 known type II diabetics and 100 age-matched non diabetics without inflammatory conditions were used as controls. Fasting plasma glucose, lipids and hs-CRP were assayed, Body mass index was calculated by using the Quetelet formula [weight (Kg)/height (m2)]. Values presented as mean ± 2standard deviations. Student’s t test and Chi-square tests were used to compare the means and proportion between two groups respectively. Pearson correlation was utilised in comparing the relationship between the hs-CRP and other parameters. Results: In the diabetics the following plasma parameters were significantly higher (p<0.05) than in the non-diabetic controls. In mmol/L, glucose 5.44± 1.19(4.88±1.41), TC 6.03±1.16(5.01±1.39), LDL Cholesterol 5.28±1.43(3.90±1.27), TG1.12±0.58(0.81±0.29); hs-CRP 0.12±0.10mg/dl(0.07±0.04), BMI29.04±5.72Kg/ m2(23.62±5.22) There was a significant decrease in HDL Cholesterol in diabetics than in the non-diabetic controls, 1.38±0.25mmol/L (1.47±0.38). Pearson’s Correlation Coefficient for hs-CRP and BMI is 0.119(p>0.05 and was not significant). Conclusion: Data shows that there are significant increases in the parameters measured in all the diabetic subjects except in HDL-cholesterol where there is significant reduction when compared with the control (P<0.05). There is no significant correlation between the hsC-reactive protein and BMI (P>0.05). The results concluded that total Cholesterol, triglyceride, low density lipoprotein cholesterol and hs–CRP have strong associations with type 2 diabetes mellitus, the significance of these associations was discussed.

Authors and Affiliations

Okeke Nduka

Keywords

Related Articles

MUTATIONS OF THE HUMAN CYP1B1 GENE IN PATIENTS WITH PRIMARY CHILDHOOD GLAUCOMA'S IN NIGERIA.

Purpose: One of the primary molecular defect underlying the majority of Childhood Glaucoma cases has been identified as mutations in the cytochrome P4501B1 (CYP1B1) gene. There are no documented molecular studies on the...

A BRIEF REVIEW ON PROCESS ANALYTICAL TECHNOLOGY

Process analytical technology (PAT) has been defined as a mechanism to design, analyze and control pharmaceutical manufacturing processes through measurement of critical process parameters which affect critical quality a...

MORPHOMETRY OF THE BONY PELVIS

The pelvis has shown to have diversed functions, thus this study is to assess the shape and dimension of the pelvis in a Nigerian populaion. Convenient sampling was done and a total of 1500 Anterior posterior pelvic radi...

PREVALENCE OF CARDIOVASCULAR RISK FACTORS; OBESITY, HYPERTENSION, DYSLIPIDEMIA AND PHYSICAL INACTIVITY AMONG TYPE 2 SAUDI DIABETIC PATIENTS.

Purpose: To estimate the prevalence and determinants of cardiovascular risk factors among diabetic patients in Qassim, Saudi Arabia. Methods: This cross sectional study was performed in 2017 and evaluated diabetic patien...

DICHLORVOS CURTAILS SEXUAL BEHAVIOR AND FERTILITY IN MALE SPRAGUE-DAWLEY RATS

Dopamine (DA) activity in the medial preoptic area (MPOA) contributes to the control of sexual behavior in adult male rat. The presence of testosterone is permissive for DA release in the MPOA, both during basal conditio...

Download PDF file
  • EP ID EP630384
  • DOI -
  • Views 147
  • Downloads 0

How To Cite

Okeke Nduka (2017). HIGH SENSITIVITY C-REACTIVE PROTEIN AND PLASMA LIPIDS IN TYPE 2DIABETIC PATIENTS IN ENUGU, NIGERIA.. European Journal of Biomedical and Pharmaceutical Sciences, 4(11), 96-102. https://europub.co.uk./articles/-A-630384